A sweeping analysis of more than six million patient records has surfaced a quiet but consequential overlap: young people diagnosed with type 2 diabetes are far more likely to be autistic or have ADHD than their peers without the disease. Presented at a major European diabetes conference, the findings from the University of Leicester invite medicine to reckon with the ways its systems have been designed for a narrower range of minds than those it actually serves. The data does not assign cause, but it does assign responsibility — to health systems that have yet to meet neurodivergent patients
Neurodiversity Strongly Linked to Early-Onset Type 2 Diabetes in Young People
Neurodivergent individuals with early-onset type 2 diabetes face poorer health outcomes, longer lifetime disease exposure, and barriers to accessing appropriate healthcare support.
Health systems are failing to fully meet the needs of this population
Mark
So this is saying that autistic and ADHD young people are getting type 2 diabetes more often. But is that because neurodiversity causes diabetes, or because something else is happening?
Mimi
The researchers can't say for certain—that's the honest answer. They found the association is real and strong, especially in young people, but the study design doesn't let them prove one causes the other. There could be shared risk factors, or neurodivergent people might have more healthcare contact, which means more chances to get diagnosed.
Luke
Right, and that's important to flag. The study looked at hospital records, so it's only capturing people who actually went to the hospital. Healthier people without diabetes might not show up in those records at all, which could make the association look stronger than it really is in the general population.
Mark
What about the mechanisms they mention—lower activity, sleep problems, that kind of thing?
Mimi
Those are possibilities the researchers listed, but they didn't measure them directly in this study. They're saying future research should dig into whether those factors actually explain the link. There's also the idea that maternal diabetes might affect both neurodevelopment and later metabolic health, which is a longer-term pathway.
Luke
And that's speculative too. The study is observational, so they're connecting dots without being able to trace the line. What they can say with confidence is that the prevalence numbers are real—14 percent ADHD, 5 percent autism in young people with early-onset diabetes.
Mark
Why does it matter so much that these young people are neurodivergent?
Mimi
Because managing diabetes is hard enough. Add in the fact that you might struggle with executive function, or sensory overwhelm in a busy clinic, or communication differences, and suddenly the whole system becomes harder to navigate. The research is saying health systems haven't designed care with that in mind.
Luke
And that's the real finding here—not the cause, but the gap in care. The study is essentially saying: we see this population, it's underserved, and we need to think differently about how we support them.
O Pulso
- Among people diagnosed with type 2 diabetes before age 20, ADHD appeared at twice the rate and autism at three times the rate compared to peers without diabetes — a gap that shrank dramatically with age, suggesting something distinctive is happening in youth.
- Early-onset type 2 diabetes already carries a heavier burden than later diagnosis, exposing people to decades more disease, higher complication risk, and earlier death — and neurodivergent individuals face all of this with fewer tools to navigate complex healthcare systems.
- Busy clinical environments, rigid appointment structures, and communication styles built for neurotypical patients create compounding barriers for those who most need consistent, well-coordinated care.
- Researchers are calling for both deeper investigation into the biological and developmental mechanisms linking these conditions and practical trials of neurodiversity-informed diabetes care to test whether tailored support actually improves outcomes.
- For now, the study positions a largely overlooked population at the center of an urgent design question: not whether medicine can treat these patients, but whether it has ever truly been built for them.
A sweeping analysis of more than six million patient records has surfaced a quiet but consequential overlap: young people diagnosed with type 2 diabetes are far more likely to be autistic or have ADHD than their peers without the disease. Presented at a major European diabetes conference, the findings from the University of Leicester invite medicine to reckon with the ways its systems have been designed for a narrower range of minds than those it actually serves. The data does not assign cause, but it does assign responsibility — to health systems that have yet to meet neurodivergent patients where they are.
A large-scale analysis of 6.3 million patient records spanning two decades of U.S. healthcare data has found a striking pattern at the intersection of neurodevelopment and metabolic disease. Among people diagnosed with type 2 diabetes before the age of 20, ADHD was present in roughly 14 percent of cases — nearly double the rate seen in similarly aged peers without diabetes. Autism showed an even sharper divide, appearing more than three times as often in the youngest diabetic group. The findings were presented at the Annual Meeting of the European Association for the Study of Diabetes in Milan.
Dr. Jonathan Goldney and colleagues at the University of Leicester matched 4.2 million newly diagnosed diabetes patients against peers by age, sex, ethnicity, and birth year, then tracked how the relationship between neurodiversity and diabetes shifted across the lifespan. The pattern was consistent: the gap was widest in youth and narrowed steadily with age, becoming modest by the seventies. This age-dependent signal suggests that whatever is driving the association is most active — or most visible — early in life.
The consequences are not merely statistical. Early-onset type 2 diabetes means a longer lifetime of disease management, greater risk of complications, and higher rates of premature death. Layered onto this, neurodivergent individuals frequently struggle with the very demands diabetes care places on them — navigating clinical environments, communicating with providers, and sustaining the daily routines the condition requires. Stigma and the pressures of early adulthood compound these difficulties further.
The researchers explored several possible explanations: reduced physical activity, sleep disruption, certain medications, mental health conditions, and even prenatal factors such as maternal diabetes, which has been linked to both neurodevelopmental and cardiometabolic outcomes in children. They were careful to note the study cannot establish causation, and acknowledged that people with neurodivergent conditions may have more frequent hospital contact, potentially inflating recorded prevalence.
Dr. Goldney was clear that the findings do not predict diabetes for most neurodivergent people. What they do demand is a redesign of how care is delivered — adjusting communication, appointment structures, and support systems to meet patients whose needs have long been treated as peripheral. The researchers call for future work to probe the underlying mechanisms and to test whether neurodiversity-informed care actually produces better health outcomes for this underserved and largely invisible population.
A large analysis of patient records has found that young people diagnosed with type 2 diabetes are far more likely to also have autism or ADHD than their peers without the disease. The research, drawn from 6.3 million patient records across the United States between 2006 and 2026, reveals a striking pattern: among people diagnosed with type 2 diabetes before age 20, ADHD appears in 14.4 percent of cases, compared to 6.9 percent among similarly aged people without diabetes. Autism shows an even sharper divide—5.72 percent among the youngest diabetics versus 1.79 percent in the non-diabetic comparison group. The findings will be presented this week at the Annual Meeting of the European Association for the Study of Diabetes in Milan.
Dr. Jonathan Goldney and his team at the University of Leicester examined data from 4.2 million people newly diagnosed with type 2 diabetes, matching each person by age, birth year, sex, ethnicity, and race to individuals without the disease. The researchers grouped patients into ten-year age bands to track how the relationship between neurodiversity and diabetes changed across the lifespan. What emerged was a clear pattern: the prevalence gap between neurodivergent people with and without diabetes was largest in youth and narrowed substantially with age. By the time people reached their seventies, ADHD was only 1.4 times more common among those with diabetes, and autism differences had largely flattened.
The implications are significant because early-onset type 2 diabetes—defined as diagnosis before age 40—carries serious consequences. People diagnosed young face a longer lifetime of managing the disease, which increases their risk of complications and premature death. Yet the research suggests that health systems are not adequately equipped to serve this population, particularly when neurodiversity is part of the picture. Neurodivergent individuals often struggle to navigate busy clinical environments, communicate effectively with healthcare providers, and manage the daily demands of diabetes care. These challenges compound existing barriers: stigma, the pressures of early adulthood, and the sheer complexity of coordinating multiple conditions.
The researchers considered several possible explanations for the association. Lower physical activity levels, sleep difficulties, certain medications, and mental health conditions may all play roles. There may also be earlier-life factors at work—maternal diabetes, for instance, has been linked to both neurodevelopmental outcomes and later cardiometabolic risk in children. The team was careful to note that the study cannot prove causation. The analysis relied on anonymized hospital records, which can contain errors and were not designed for research purposes. People with neurodivergent conditions may also have more frequent healthcare contact, which could increase the likelihood of a diabetes diagnosis being recorded. Additionally, because the study only captured people who had attended hospital, it may not fully represent the broader population, potentially skewing prevalence estimates.
Dr. Goldney emphasized that the findings do not suggest most neurodivergent people will develop type 2 diabetes. Rather, the elevated prevalence among those diagnosed young should inform how clinical services are designed and delivered. Taking neurodiversity into account—adjusting communication styles, appointment structures, and support systems—could reduce barriers to care and improve engagement with treatment. The researchers call for future studies to investigate the underlying mechanisms linking these conditions and to test whether diabetes care tailored to neurodivergent needs actually produces better health outcomes. For now, the data points to a population that has been largely invisible in diabetes care planning, despite facing compounded challenges that demand attention.
Citações Notáveis
Neurodivergent people and those living with early-onset T2D are likely to face unique challenges when navigating busy healthcare environments, communicating with healthcare professionals, and managing their diabetes.— Dr. Jonathan Goldney, University of Leicester Diabetes Research Centre
Our findings by no means suggest that most people with a neurodivergent condition will go on to develop type 2 diabetes. However, the higher prevalence of neurodiversity among people diagnosed with T2D earlier in life should be considered when planning services.— Dr. Jonathan Goldney
Quer a matéria completa?
Leia o original em eurekalert.org ↗